Case Study: Claritas discovers novel variant in patient suffering from seizures Changing patient care by opening up the underlying whole exome A patient at Boston Children’s Hospital, a young adult, had suffered from seizures for more than 16 years. The patient’s neurologist ordered Claritas’ Pediatric Neurology Exome, a test that investigated 614 genes for variants…
Read MoreA variety of opportunities are available to the clinical researcher, including access to individual patient’s genomic data for ordering clinicians with a research interest, and de-identified aggregated genomic data for clinicians with research interest in specific disease states. Read on to learn more. Underlying exome data transitioned to research use Our partnership with WuXi-NextCODE allows us to…
Read MoreOur Purpose Our goal is to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best…
Read MoreGenetic testing is often an expensive process, and costs can deter providers and families from obtaining necessary testing. Claritas has developed billing and financial programs to minimize expense for patients at all levels of income and insurance. In addition, Claritas works directly with familes and insurance providers to resolve denied claims and/or patient financial responsibility…
Read MoreExecutive Leadership Hannes Thor Smárason – Member of the Board of Directors, Interim CEO. Co-Founder of NextCODE Health Hannes Thor Smárason is a prolific entrepreneur, investor, and advisor. Mr. Smárason co-founded NextCODE Health along with Dr. Jeff Gulcher. He has been a longtime advisor to deCODE and its venture investors Polaris Venture Partners and ARCH Venture…
Read MoreCAMBRIDGE, Massachusetts, December 18, 2014 Claritas Genomics today announced the appointment of Patrick F. Terry to the role of Chief Commercial Officer. Mr. Terry, Chairman, Gray Group Ventures Ltd., and a founder of Genomic Health, Inc. [NASDAQ: GHDX], has been involved in shepherding multiple biotechnology products through commercial development to clinical delivery. Mr. Terry will…
Read MoreTim Yu, MD, PhD Principal Consultant/Co-Founder As a principal Consultant in Claritas, Tim plays a key role in informatics and software development used in analyzing and interpreting genomic data sets. Tim Yu is a neurologist and researcher at Boston Children’s Hospital with broad expertise in genomics, molecular biology, informatics, and personalized medicine. His research focuses…
Read MorePlease complete this form to submit an request for Specimen Collection Kits. Our specimen collection kits support the shipment of blood and DNA and can only be shipped to and from hospitals in the United States. If you require the shipment of other sample types or if you require samples to be shipped from outside…
Read MoreClaritas Genomics is a CLIA-certified genetic diagnostic testing company that combines the power of genetic analysis technology with the clinical expertise of the world’s best pediatric specialists to inform and improve patient care. Claritas offers a range of services that take the guesswork out of test ordering and support clinicians as they navigate an increasingly…
Read MoreBob Higgins Chairman Bob Higgins is a Senior Lecturer at Harvard Business School and a Founder and General Partner at Causeway Media Partners. Causeway is focused on backing young growth companies in sports media. Bob is also Founding Partner at Highland Capital Partners. He created and currently teaches a course at HBS called Entrepreneurship in…
Read More